Restricted accessResearch articleFirst published online 2015-08
Obesity-Associated Inflammatory Cytokines and Prostaglandin E2 Stimulate Glucose Transporter mRNA Expression and Glucose Uptake in Primary Human Adipose Stromal Cells
Obesity is associated with chronic low-grade inflammation. This occurs largely as a result of the infiltration of immune cells within the obese adipose, which produce a number of inflammatory factors, including interleukin-6 (IL-6), IL-1β, tumor necrosis factor-α (TNFα), and prostaglandin E2 (PGE2). These factors have previously been shown to affect insulin-mediated glucose uptake in differentiated adipocytes. However, the insulin-independent effect of inflammation on adipocyte precursors, the adipose stromal cells, has not been explored. This study therefore aimed to examine the effect of obesity-associated inflammatory factors on the expression of insulin-independent glucose transporters (GLUT1 and GLUT3) and on the uptake of glucose within adipose stromal cells. Primary human subcutaneous adipose stromal cells were isolated from abdominoplasty, and the effect of inflammatory cytokines (IL-6, IL-1β, and TNFα) and PGE2 on GLUT mRNA expression and glucose transport was assessed using real-time polymerase chain reaction and radiolabeled deoxyglucose uptake assays, respectively. Results demonstrate that all four inflammatory mediators caused a dose-dependent increase in GLUT1 mRNA expression and glucose uptake. GLUT3 mRNA expression was also upregulated by IL-6 (0.5 ng/mL), TNFα (0.1 and 10 ng/mL), and PGE2 (0.1 μM). Overall, these results demonstrate that obesity-associated inflammation increases insulin-independent glucose transporter expression and glucose uptake in undifferentiated adipose stromal cells.
Get full access to this article
View all access options for this article.
References
1.
AckermanGE, SmithME, MendelsonCR, MacDonaldPC, SimpsonER. 1981. Aromatization of androstenedione by human adipose tissue stromal cells in monolayer culture. J Clin Endocrinol Metab, 53(2):412–417.
2.
BackK, ArnqvistHJ. 2009. Changes in insulin and IGF-I receptor expression during differentiation of human preadipocytes. Growth Horm IGF Res, 19(2):101–111.
3.
BertiL, GammeltoftS. 1999. Leptin stimulates glucose uptake in C2C12 muscle cells by activation of ERK2. Mol Cell Endocrinol, 157(1–2):121–130.
4.
BrownKA. 2014. Impact of obesity on mammary gland inflammation and local estrogen production. J Mammary Gland Biol Neoplasia, 19(2):183–189.
5.
BrownKA, McInnesKJ, HungerNI, OakhillJS, SteinbergGR, SimpsonER. 2009. Subcellular localization of cyclic AMP-responsive element binding protein-regulated transcription coactivator 2 provides a link between obesity and breast cancer in postmenopausal women. Cancer Res, 69(13):5392–5399.
6.
ChuenCK, LiK, YangM, FokTF, LiCK, ChuiCM, YuenPM. 2004. Interleukin-1beta up-regulates the expression of thrombopoietin and transcription factors c-Jun, c-Fos, GATA-1, and NF-E2 in megakaryocytic cells. J Lab Clin Med, 143(2):75–88.
7.
CiaraldiTP, AbramsL, NikoulinaS, MudaliarS, HenryRR. 1995. Glucose transport in cultured human skeletal muscle cells. Regulation by insulin and glucose in nondiabetic and non-insulin-dependent diabetes mellitus subjects. J Clin Invest, 96(6):2820–2827.
8.
DangCV. 2012. Links between metabolism and cancer. Genes Dev, 26(9):877–890.
9.
DugailI, Quignard-BoulangeA, DupuyF. 1986. Role of adipocyte precursors in the onset of obesity induced by overfeeding in suckling rats. J Nutr, 116(4):524–535.
10.
EbelingP, KoistinenHA, KoivistoVA. 1998. Insulin-independent glucose transport regulates insulin sensitivity. FEBS Lett, 436(3):301–303.
11.
FlierJS, MuecklerMM, UsherP, LodishHF. 1987. Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science, 235(4795):1492–1495.
12.
FukuyoS, YamaokaK, SonomotoK, OshitaK, OkadaY, SaitoK, YoshidaY, KanazawaT, MinamiY, TanakaY. 2014. IL-6-accelerated calcification by induction of ROR2 in human adipose tissue-derived mesenchymal stem cells is STAT3 dependent. Rheumatology (Oxford), 53(7):1282–1290.
13.
Grahame HardieD. 2014. AMP-activated protein kinase: a key regulator of energy balance with many roles in human disease. J Intern Med, 276:543–559.
14.
HartCD, FlozakAS, SimmonsRA. 1998. Modulation of glucose transport in fetal rat lung: a sexual dimorphism. Am J Respir Cell Mol Biol, 19(1):63–70.
15.
HaunerH, RohrigK, SpellekenM, LiuLS, EckelJ. 1998. Development of insulin-responsive glucose uptake and GLUT4 expression in differentiating human adipocyte precursor cells. Int J Obes Relat Metab Disord, 22(5):448–453.
16.
HirakiY, RosenOM, BirnbaumMJ. 1988. Growth factors rapidly induce expression of the glucose transporter gene. J Biol Chem, 263(27):13655–13662.
17.
HotamisligilGS, ShargillNS, SpiegelmanBM. 1993. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science, 259(5091):87–91.
18.
IwabuchiS, KawaharaK. 2013. Extracellular ATP-prinoceptor signaling and AMP-activated protein kinase regulate astrocytic glucose transporter 3 in an in vitro ischemia. Neurochem Int, 63(4):259–268.
19.
JinN, QianW, YinX, ZhangL, IqbalK, Grundke-IqbalI, GongCX, LiuF. 2013. CREB regulates the expression of neuronal glucose transporter 3: a possible mechanism related to impaired brain glucose uptake in Alzheimer's disease. Nucleic Acids Res, 41(5):3240–3256.
20.
KaoYS, FongJC. 2011. A novel cross-talk between endothelin-1 and cyclic AMP signaling pathways in the regulation of GLUT1 transcription in 3T3-L1 adipocytes. Cell Signal, 23(5):901–910.
21.
KozlovskyN, RudichA, PotashnikR, EbinaY, MurakamiT, BashanN. 1997. Transcriptional activation of the Glut1 gene in response to oxidative stress in L6 myotubes. J Biol Chem, 272(52):33367–33372.
22.
KrasKM, HausmanDB, MartinRJ. 2000. Tumor necrosis factor-alpha stimulates cell proliferation in adipose tissue-derived stromal-vascular cell culture: promotion of adipose tissue expansion by paracrine growth factors. Obes Res, 8(2):186–193.
23.
Krogh-MadsenR, PlomgaardP, MollerK, MittendorferB, PedersenBK. 2006. Influence of TNF-alpha and IL-6 infusions on insulin sensitivity and expression of IL-18 in humans. Am J Physiol Endocrinol Metab, 291(1):E108–E114.
24.
KrzeslakA, Wojcik-KrowirandaK, FormaE, JozwiakP, RomanowiczH, BienkiewiczA, BrysM. 2012. Expression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancers. Pathol Oncol Res, 18(3):721–728.
25.
LarsenCM, FaulenbachM, VaagA, VolundA, EhsesJA, SeifertB, Mandrup-PoulsenT, DonathMY. 2007. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med, 356(15):1517–1526.
26.
Marin-HernandezA, Gallardo-PerezJC, RalphSJ, Rodriguez-EnriquezS, Moreno-SanchezR. 2009. HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms. Mini Rev Med Chem, 9(9):1084–1101.
27.
NikulinaMA, SandhuN, ShamimZ, AndersenNA, ObersonA, DuprazP, ThorensB, KarlsenAE, BonnyC, Mandrup-PoulsenT. 2003. The JNK binding domain of islet-brain 1 inhibits IL-1 induced JNK activity and apoptosis but not the transcription of key proapoptotic or protective genes in insulin-secreting cell lines. Cytokine, 24(1–2):13–24.
28.
OgataA, MorishimaA, HiranoT, HishitaniY, HagiharaK, ShimaY, NarazakiM, TanakaT. 2011. Improvement of HbA1c during treatment with humanised anti-interleukin 6 receptor antibody, tocilizumab. Ann Rheum Dis, 70(6):1164–1165.
29.
PrzybytE, KrenningG, BrinkerMG, HarmsenMC. 2013. Adipose stromal cells primed with hypoxia and inflammation enhance cardiomyocyte proliferation rate in vitro through STAT3 and Erk1/2. J Transl Med, 11:39.
30.
RichelsenB, HjollundE, PedersenO, SorensenNS. 1985. Effects of prostaglandin E2, indomethacin and adenosine deaminase on basal and insulin-stimulated glucose metabolism in human adipocytes. Biochim Biophys Acta, 844(3):359–366.
31.
RoyerC, LachuerJ, CrouzoulonG, RouxJ, PeyronnetJ, MametJ, PequignotJ, DalmazY. 2000. Effects of gestational hypoxia on mRNA levels of Glut3 and Glut4 transporters, hypoxia inducible factor-1 and thyroid hormone receptors in developing rat brain. Brain Res, 856(1–2):119–128.
32.
SamarajeewaNU, YangF, DocantoMM, SakuraiM, McNamaraKM, SasanoH, FoxSB, SimpsonER, BrownKA. 2013. HIF-1alpha stimulates aromatase expression driven by prostaglandin E2 in breast adipose stroma. Breast Cancer Res, 15(2):R30.
33.
SantaluciaT, ChristmannM, YacoubMH, BrandNJ. 2003. Hypertrophic agonists induce the binding of c-Fos to an AP-1 site in cardiac myocytes: implications for the expression of GLUT1. Cardiovasc Res, 59(3):639–648.
34.
Schwartzenberg-Bar-YosephF, ArmoniM, KarnieliE. 2004. The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res, 64(7):2627–2633.
35.
van HarmelenV, SkurkT, RohrigK, LeeYM, HalbleibM, Aprath-HusmannI, HaunerH. 2003. Effect of BMI and age on adipose tissue cellularity and differentiation capacity in women. Int J Obes Relat Metab Disord, 27(8):889–895.
36.
VannucciSJ, ReinhartR, MaherF, BondyCA, LeeWH, VannucciRC, SimpsonIA. 1998. Alterations in GLUT1 and GLUT3 glucose transporter gene expression following unilateral hypoxia-ischemia in the immature rat brain. Brain Res Dev Brain Res, 107(2):255–264.
37.
WangX, DocantoMM, SasanoH, kConFab, LoC, SimpsonER, BrownKA. 2015. Prostaglandin E2 inhibits p53 in human breast adipose stromal cells: a novel mechanism for the regulation of aromatase in obesity and breast cancer. Cancer Res, 75(4):645–655.
38.
WeisbergSP, McCannD, DesaiM, RosenbaumM, LeibelRL, FerranteAWJr. 2003. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest, 112(12):1796–1808.
39.
WoodIS, TrayhurnP. 2003. Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins. Br J Nutr, 89(1):3–9.
ZhaoY, NicholsJE, BulunSE, MendelsonCR, SimpsonER. 1995. Aromatase P450 gene expression in human adipose tissue. Role of a Jak/STAT pathway in regulation of the adipose-specific promoter. J Biol Chem, 270(27):16449–16457.
42.
ZhaoY, NicholsJE, ValdezR, MendelsonCR, SimpsonER. 1996. Tumor necrosis factor-alpha stimulates aromatase gene expression in human adipose stromal cells through use of an activating protein-1 binding site upstream of promoter 1.4. Mol Endocrinol, 10(11):1350–1357.
